Relmada Therapeutics
New York, US
Biotech
Founders & leadership
ST
Sergio TraversaExecutive Officer, Director
CC
Charles CasamentoDirector
PK
Paul KellyDirector
MS
Maged ShenoudaDirector
Reported raises · per SEC filings
Form D private placements$825.8KraisedOct 2019 · 7 investors · Biotechnology
Rule 506(b)$8.4MraisedJul 2019 · 116 investors · Biotechnology
Rule 506(b)$3.4MraisedMay 2019 · 43 investors · Biotechnology
Rule 506(b)$5.8MraisedDec 2018 · 66 investors · Biotechnology
Rule 506(b)$6.9MraisedOct 2017 · 65 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.